-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
-
Summary
-
MoonLake Immunotherapeutics quarterly/annual Return On Assets history and growth rate from 2021 to Q3 2025.
- MoonLake Immunotherapeutics Return On Assets for the quarter ending September 30, 2025 was -45.2 %, a 201% decline year-over-year.
- MoonLake Immunotherapeutics annual Return On Assets for 2024 was -22.6 %, a 151% decline from 2023.
- MoonLake Immunotherapeutics annual Return On Assets for 2023 was -9 %, a 77.7% increase from 2022.
- MoonLake Immunotherapeutics annual Return On Assets for 2022 was -40.4 %, a 697% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)